NEUROLOGICAL IMPLANTS SHOULD UNDERGO SPECIFIC BIOCOMPATIBILITY TESTS
This article was originally published in The Gray Sheet
Executive SummaryNEUROLOGICAL IMPLANTS SHOULD UNDERGO SPECIFIC BIOCOMPATIBILITY TESTS, FDA's Neurological Devices Advisory Panel suggested during a Sept. 16 meeting in Gaithersburg, Maryland. "The brain has to be looked at for its unique and multiple characteristics," said panel member Roger Contee, MD, Robert Wood Johnson Medical School, New Brunswick, New Jersey. "I think we need to study [implantation] in more detail...because of the very variegated effects" which materials can have on the brain.
You may also be interested in...
The US FDA has overhauled its ‘Purple Book’ to make it a searchable database of biologics information. The agency is also seeking input on next steps.
The International Council for Harmonisation has replaced its 1993 guideline on reproductive toxicity studies with an updated version.
Stada says it has become a "major consumer healthcare player" after signing a deal to acquire from GSK 15 brands, which generate annual sales of around €120m.